For instance, the specific antagonist SHP099 targeting Src homology 2 domain-containing phosphatase 2 (SHP2) can reduce sorafenib resistance in HCC cell lines and organoids, the mechanism of which was achieved by the induced senescence [130]. The gene discussed is PTPN11; the disease is hepatocellular carcinoma.